Live Breaking News & Updates on Gd Searle

Stay updated with breaking news from Gd searle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Unichem Labs gains ater USFDA approval for celecoxib capsules


Unichem Laboratories gained 1.15% to Rs 280.85 after the company said it received US drug regulator s approval for celecoxib capsules, an anti-inflammatory drug.
In a regulatory filing made during market hours today, the company said that it had received ANDA approval for its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (US FDA). The product is a generic version of Celebrex capsules of G.D. Searle LLC, Division of Pfizer Inc.
Celecoxib capsules are indicated for treatment of osteoarthritis, rheumatoid arthritis juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain and primary dysmenorrhea.
The product will be commercialized from Unichem s Goa Plant, the company said in a statement. ....

United States , Gd Searle , Drug Administration , Division Of Pfizer Inc , Unichem Laboratories , Celecoxib Capsules , United States Food , Goa Plant , Capital Market , Non Steroidal Anti Inflammatory Drugs , Cox 2 Inhibitors , Health Sciences , Treatment Of Osteoarthritis , Pfizer Inc , Rheumatoid Arthritis Juvenile , ஒன்றுபட்டது மாநிலங்களில் , க்ட் தேடல் , பிரிவு ஆஃப் ஃபைசர் இன்க் , ஒன்றுபட்டது மாநிலங்களில் உணவு , கோவா ஆலை , மூலதனம் சந்தை , ஆரோக்கியம் அறிவியல் , சிகிச்சை ஆஃப் ஆஸ்டியோவார்த்ரைடிஸ் , ஃபைசர் இன்க் , முடக்கு கீல்வாதம் இளம் ,